Single nucleotide polymorphisms in toll-like receptor 6 are associated with altered lipopeptide- and mycobacteria-induced interleukin-6 secretion.
Toll-like receptors (TLRs) are critical mediators of the immune response to pathogens. The influence of human TLR6 polymorphisms on susceptibility to infection is only partially understood. Most microbes contain lipopeptides recognized by TLR2/1 or TLR2/6 heterodimers. Our aim was to determine whether single nucleotide polymorphisms in TLR6 are associated with altered immune responses to lipopeptides and whole mycobacteria. We sequenced the TLR6 coding region in 100 healthy South African adults to assess genetic variation and determined associations between polymorphisms and lipopeptide- and mycobacteria-induced interleukin (IL)-6 production in whole blood. We found two polymorphisms, C745T and G1083C, that were associated with altered IL-6 secretion. G1083C was associated with altered IL-6 levels in response to lipopeptides, Mycobacterium tuberculosis lysate (Mtb lysate, P=0.018) and Bacille Calmette-Guerin (BCG P=0.039). The 745T allele was also associated with lower NF-κB signaling in response to di-acylated lipopeptide, PAM2 (P=0.019) or Mtb (P=0.026) in an HEK293 cell line reconstitution assay, compared with the 745C allele. We conclude that TLR6 polymorphisms may be associated with altered lipopeptide-induced cytokine responses and recognition of Mtb. These studies provide new insight into the role of TLR6 variation and the innate immune response to human infection.
Shey
M S
MS
South African Tuberculosis Vaccine Initiative, University of Cape Town, South Africa.
Randhawa
A K
AK
Bowmaker
M
M
Smith
E
E
Scriba
T J
TJ
de Kock
M
M
Mahomed
H
H
Hussey
G
G
Hawn
T R
TR
Hanekom
W A
WA
D000328:Adult; D016207:Cytokines / Q000235:genetics; D057809:HEK293 Cells; D006801:Humans; D007155:Immunologic Factors / Q000235:genetics; D015850:Interleukin-6 / Q000378:metabolism*; D055666:Lipopeptides / Q000378:metabolism; D009161:Mycobacterium; D009163:Mycobacterium bovis / Q000235:genetics / Q000378:metabolism; D009169:Mycobacterium tuberculosis / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D016328:NF-kappa B / Q000235:genetics / Q000378:metabolism; D020641:Polymorphism, Single Nucleotide; D015398:Signal Transduction / Q000235:genetics / Q000276:immunology; D051216:Toll-Like Receptor 6 / Q000235:genetics*; D051193:Toll-Like Receptors / Q000378:metabolism
D016207:Cytokines; D007155:Immunologic Factors; D015850:Interleukin-6; D055666:Lipopeptides; D016328:NF-kappa B; D051216:Toll-Like Receptor 6; D051193:Toll-Like Receptors
Ann N Y Acad Sci. 2005 Dec;1062:95-103
16461792
BMC Immunol. 2008 Aug 08;9:46
18691413
Eur J Immunogenet. 1998 Apr-Jun;25(2-3):267
9615916
Infect Immun. 2004 Mar;72(3):1657-65
14977973
Proc Natl Acad Sci U S A. 1999 Dec 7;96(25):14459-63
10588727
J Exp Med. 2005 Dec 19;202(12):1715-24
16365150
J Immunol. 2001 Jul 15;167(2):987-94
11441107
Infect Immun. 2000 Nov;68(11):6398-401
11035751
Science. 1998 Dec 11;282(5396):2085-8
9851930
Immunol Rev. 2009 Jan;227(1):221-33
19120487
Immunology. 2000 Sep;101(1):1-10
11012747
J Mol Med (Berl). 2003 Jun;81(6):368-72
12743710
Int Immunopharmacol. 2004 Oct;4(10-11):1287-300
15313427
J Immunol. 2005 Aug 15;175(4):2534-40
16081826
Eur J Immunol. 2002 Dec;32(12):3337-47
12432564
Mol Cell Proteomics. 2002 Apr;1(4):304-13
12096112
Annu Rev Genomics Hum Genet. 2001;2:373-400
11701655
Microbiology (Reading). 2007 Mar;153(Pt 3):652-658
17322184
Clin Sci (Lond). 2008 Mar;114(5):347-60
18230059
Trends Immunol. 2006 Jan;27(1):49-55
16310411
Genes Immun. 2004 Aug;5(5):343-6
15266299
J Biol Chem. 2006 Apr 7;281(14):9049-57
16455646
Methods Mol Biol. 2003;212:241-62
12491915
Int Immunol. 2001 Jul;13(7):933-40
11431423
Genome Res. 1998 Mar;8(3):195-202
9521923
BMC Med Genet. 2005 Sep 28;6:34
16188043
J Immunol. 2003 Apr 1;170(7):3451-4
12646604
J Biol Chem. 2005 Nov 4;280(44):36616-25
16129684
Genome Biol. 2003;4(9):117
12952525
PLoS Genet. 2009 Jul;5(7):e1000562
19609346
Annu Rev Genet. 2006;40:469-86
17094741
Tissue Antigens. 2006 Feb;67(2):97-110
16441480
Immunol Rev. 2009 Jan;227(1):248-63
19120489
Cell. 2006 Feb 24;124(4):783-801
16497588
J Immunol. 2007 Jun 15;178(12):7520-4
17548585
J Immunol. 2002 Jul 1;169(1):10-4
12077222
Curr Protoc Bioinformatics. 2003 Aug;Chapter 11:Unit11.2
18428695
J Immunol. 2006 Jul 1;177(1):422-9
16785538
J Immunol. 2008 May 1;180(9):6149-58
18424736
Eur J Immunol. 2007 Aug;37(8):2280-9
17595679
PLoS One. 2007 Dec 19;2(12):e1318
18091991
J Immunol. 1999 Oct 1;163(7):3920-7
10490993
Vaccine. 2008 Mar 25;26(14):1731-6
18325643
Lancet Infect Dis. 2005 Mar;5(3):156-64
15766650
J Clin Invest. 1998 Oct 1;102(7):1369-76
9769329
Am J Respir Crit Care Med. 2008 Oct 1;178(7):710-20
18635889